£185.99

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy

Pharmacology

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£186 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days • 74 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price

Price Analysis

Most common price: £186 (74 days, 100.0%)

Price range: £186 - £186

Price levels: 1 different prices over 74 days

Description

The class of serotonin and noradrenaline reuptake inhibitors (or SNRIs) were introduced into clinical use as a result of the perceived short-comings of other antidepressant medications. Considerations of efficacy, side effects and tolerability have consistently indicated that there is a clinical need for agents demonstrating improvements in one or more of these domains. Since its introduction in 2007, duloxetine, a representative of the SNRI class, has been shown to be as effective for the treatment of major depression as agents with a longer history of use. In addition, duloxetine has demonstrated efficacy in a number of other conditions and has been extensively investigated in the treatment of generalised anxiety disorder and neuropathic pain states. The effectiveness of duloxetine in other anxiety states is not as soundly investigated, but the extant evidence is reviewed. Such disorders represent a fertile ground to explore the boundaries of duloxetine therapeutics, with the attended possibility of significant benefits to a broader patient cohort. This volume brings together the clinical evidence for efficacy in these important conditions. Additionally, it explores in detail the pharmacokinetics, metabolism and mechanism of action of the drug. All medications have side effects associated with their use and duloxetine is no exception. A detailed examination of the presentation and incidence of common events associated with the use of the drug as well as rarer treatment emergent adverse events is outlined. Duloxetine presents itself as a first line treatment of major depressive disorder and as a clinically significant treatment for depressive disorders co-morbid with anxiety and pain states.

Product Specifications

Format: hardcover
ASIN: 1536143278
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 23 November 2018
Listed Since: 07 August 2018

Barcode

No barcode data available

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Differenzierte Therapie mit trizyklischen Antidepressiva

Antidepressants (Milestones in Drug Therapy)

Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Disease and Desire)

Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer

Pharmacotherapy of Depression

Melatonin, Neuroprotective Agents and Antidepressant Therapy

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

Neurobiology of Depression: Road to Novel Therapeutics

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

Depression (Primer On Series)

Pharmacotherapy of Child and Adolescent Psychiatric Disorders

Focus on Serotonin Uptake Inhibitor Research (Nova Biomedical)

Trends in Serotonin Reuptake Inhibitor Research

Major Depressive Disorder (Oxford American Psychiatry Library)

The Pharmacological Guide to Paroxetine (Pharmacology - Research, Safety Testing and Regulation)

Serotonin: ein funktioneller Ansatz für die psychiatrische Diagnose und Therapie? (duphar med communication)

The Pharmacogenetics of Antidepressant Response: Moving towards Individualized Therapy - Improving Patient Outcomes through Optimization of Treatment Based on Genetic Makeup

Rapid Acting Antidepressants: Volume 89 (Advances in Pharmacology, Volume 89)

Treatment-Resistant Mood Disorders

Cognitieve gedragstherapiebij depressie (Praktijkreeks gedragstherapie, 16)

The Massachusetts General Hospital Guide to Depression: New Treatment Insights and Options (Current Clinical Psychiatry)

Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention

Depression: A Primer for Practitioners

Clinical Depression: An Individualized, Biopsychosocial Approach to Assessment and Treatment